Clinical Trial Update: Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring the combination of incretin therapy and SGLT2 inhibition in type 2 diabetes with potential insights into heart failure mechanis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: University Health Network, Toronto | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: UNKNOWN